Home > Focus on MET exon 14 skipping alterations – a promising and rapidly evolving molecular target in NSCLC

Focus on MET exon 14 skipping alterations – a promising and rapidly evolving molecular target in NSCLC

Stay up to date with the latest developments in NSCLC with MET exon 14 skipping alterations with our touchCONGRESS Panel Discussion and Expert Interviews from the European Society for Medical Oncology (ESMO) Annual Meeting in Barcelona 27 September–1 October 2019.

Congress Activities

IME
CME and Education Activities are developed by touchIME for touchONCOLOGY.

Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.

Copied to clipboard!
accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar